Kobayashi Pharmaceutical (China) Co., Ltd.
Basic information
- Head office
- Room 507A, Building 2, No. 508 Chun Dong Road, Minhang District, Shanghai
- Chief executive
- Takaya Matsushita
- Employees (non-consolidated)
- Employees (consolidated)
- Start date
- 2018-04-09
- End date
Websites
Business
Related companies
| Company name | Group | Parent | Subsidiary | Customer | Supplier | Alliance | Bank | Shareholder |
|---|---|---|---|---|---|---|---|---|
| Shanghai Sifan Ke Trading Co., Ltd. | ||||||||
| Shanghai Wei Hengbin Technology Co., Ltd. | ||||||||
| Beijing Digital Sky Technology Co., Ltd. | ||||||||
| Beijing Haoran Yi Pin Technology Co., Ltd. | ||||||||
|
|
||||||||
| Xiamen Golden Countryside Biotechnology Co., Ltd. |
Network
History
Kobayashi Pharmaceutical (China) Co., Ltd. was established on April 9, 2018, with its registered office located at 507A, Building 2, No. 508 Chun Dong Road, Minhang District, Shanghai. The legal representative is Takaya Matsushita. The scope of business includes licensed projects: contract manufacturing of drugs; drug manufacturing; drug wholesale; drug retail; drug import and export. (Projects that require approval by law must be carried out only after approval by relevant departments, and specific business items are subject to the approval documents or licenses issued by relevant departments.) General projects: engaging in investment activities with own funds, investment management (1) investing in fields allowed for foreign investment by the state in accordance with the law; (2) upon written delegation from the invested enterprises (approved unanimously by the board of directors), providing the following services to the invested enterprises: 1) assisting or acting as an agent for the invested enterprises to procure from domestic and foreign sources the machinery, equipment, office equipment, raw materials, components, and spare parts for their own use, and to sell the products produced by the invested enterprises domestically and abroad, and providing after‑sales service; 2) balancing foreign exchange between the invested enterprises under the consent and supervision of the foreign exchange management department; 3) providing technical support, employee training, internal personnel management, and other services during the production, sales, and market development of the invested enterprises; 4) assisting the invested enterprises in seeking and providing guarantees; (3) establishing research and development centers or departments within China to conduct research and development of new products and high‑technology, transferring the R&D results, and providing corresponding technical services; (4) providing consulting services to the investors, and providing related companies with market information, investment policies, and other consulting services related to their investments; (5) undertaking outsourcing services for its parent company and related companies; (6) undertaking outsourcing services for overseas companies); wholesale of daily necessities; sale of daily necessities; sale of daily chemical products; sale of daily miscellaneous goods; sale of personal hygiene products; sale of plastic products; sale of packaging materials and products; wholesale of craft and art items and collectibles (excluding ivory and its products); wholesale of hardware products; sale of knitted and woven textiles and raw materials; sale of rubber products; sale of paper products; sale of construction materials; sale of molds; sale of machinery and equipment; sale of leather products; wholesale of cosmetics; sale of daily wooden products; sale of rattan products; sale of technical glass products; sale of chemical products (excluding licensed chemical products); wholesale of edible agricultural products; sale of metal ores; purchase and sale of herbal medicine (excluding decoction pieces); sale of Class I medical devices; sale of non‑medical daily masks; sale of disinfectants (excluding hazardous chemicals); online sales (excluding sales of goods requiring licenses); business agency and representation services; import and export of goods; leasing of machinery and equipment; information consulting services (excluding licensed information consulting services); enterprise management consulting; organization of cultural and artistic exchange activities; marketing planning; conference and exhibition services; engineering and technical research and experimental development (excluding human stem cells, gene diagnosis and therapy technology development and application, and China's rare and unique precious high‑quality varieties); biobased materials technology R&D; information technology consulting services; technical services, technical development, technical consulting, technical exchange, technology transfer, technology promotion; technology import and export; sale of Class II medical devices; sale of food (only pre‑packaged foods); sale of health food (pre‑packaged). (Except for projects that require approval by law, the company conducts business independently in accordance with its business license.) Kobayashi Pharmaceutical (China) Co., Ltd. has invested in two external companies and has four branches.![]()
News
There is no news.